HEADER TRANSFERASE/TRANSFERASE INHIBITOR 18-DEC-11 3V66 TITLE HUMAN SQUALENE SYNTHASE IN COMPLEX WITH 2-(1-{2-[(4R,6S)-8-CHLORO-6- TITLE 2 (2,3-DIMETHOXYPHENYL)-4H,6H-PYRROLO[1,2-A][4,1]BENZOXAZEPIN-4- TITLE 3 YL]ACETYL}-4-PIPERIDINYL)ACETIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: SQUALENE SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SOLUBLE DOMAIN, UNP RESIDUES 31-370; COMPND 5 SYNONYM: SQS, SS, FPP:FPP FARNESYLTRANSFERASE, FARNESYL-DIPHOSPHATE COMPND 6 FARNESYLTRANSFERASE; COMPND 7 EC: 2.5.1.21; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FDFT1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PA-426 KEYWDS TERPENOID SYNTHASE FOLD, ISOPRENE BIOSYNTHESIS, LIPID SYNTHESIS, KEYWDS 2 MULTIFUNCTIONAL ENZYME, OXIDOREDUCTASE, STEROID BIOSYNTHESIS, STEROL KEYWDS 3 BIOSYNTHESIS, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.SUZUKI,M.OHTSUKA,H.OHKI,N.HAGINOYA,M.ITOH,K.SUGITA,H.USUI, AUTHOR 2 M.ICHIKAWA,N.HIGASHIHASHI REVDAT 2 08-NOV-23 3V66 1 REMARK HETSYN REVDAT 1 19-DEC-12 3V66 0 JRNL AUTH M.ICHIKAWA,M.OHTSUKA,H.OHKI,N.HAGINOYA,M.ITOH,K.SUGITA, JRNL AUTH 2 H.USUI,M.SUZUKI,K.TERAYAMA,A.KANDA JRNL TITL DISCOVERY OF NOVEL TRICYCLIC COMPOUNDS AS SQUALENE SYNTHASE JRNL TITL 2 INHIBITORS JRNL REF BIOORG.MED.CHEM. V. 20 3072 2012 JRNL REFN ISSN 0968-0896 JRNL PMID 22464687 JRNL DOI 10.1016/J.BMC.2012.02.054 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 33401 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1771 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.86 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3122 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2340 REMARK 3 BIN FREE R VALUE SET COUNT : 162 REMARK 3 BIN FREE R VALUE : 0.2540 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2662 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 337 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.65000 REMARK 3 B22 (A**2) : -0.76000 REMARK 3 B33 (A**2) : -0.38000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.55000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.124 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.075 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.323 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2769 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3754 ; 1.345 ; 1.969 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 334 ; 4.515 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 128 ;35.951 ;23.984 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 475 ;12.536 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;14.904 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 418 ; 0.098 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2089 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1436 ; 0.207 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1981 ; 0.310 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 299 ; 0.152 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 32 ; 0.231 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 19 ; 0.217 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1737 ; 1.050 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2707 ; 1.569 ; 2.500 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1196 ; 1.512 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1047 ; 2.280 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL PARAMETERS FOR MASK CACLULATION REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : NULL REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RIGID BODY REFINEMENT REMARK 4 REMARK 4 3V66 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000069644. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : CONFOCAL MIRROR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35196 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : 2.420 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.32 REMARK 200 R MERGE FOR SHELL (I) : 0.17000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 3Q30 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CO-CRYSTALLIZED USING SEEDING METHOD., REMARK 280 PH 5, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 43.71900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.07200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 43.71900 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.07200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 31 REMARK 465 ASP A 32 REMARK 465 GLN A 33 REMARK 465 ASP A 34 REMARK 465 SER A 35 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 41 CE NZ REMARK 470 ARG A 52 NE CZ NH1 NH2 REMARK 470 GLU A 113 CD OE1 OE2 REMARK 470 LYS A 115 CD CE NZ REMARK 470 ARG A 119 CZ NH1 NH2 REMARK 470 GLN A 120 CG CD OE1 NE2 REMARK 470 GLN A 166 CD OE1 NE2 REMARK 470 GLU A 222 CD OE1 OE2 REMARK 470 LYS A 241 CE NZ REMARK 470 LYS A 242 CE NZ REMARK 470 LYS A 311 CE NZ REMARK 470 LYS A 315 CD CE NZ REMARK 470 LYS A 318 CE NZ REMARK 470 GLU A 343 CD OE1 OE2 REMARK 470 ASP A 351 CG OD1 OD2 REMARK 470 ASN A 370 CB CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 588 O HOH A 779 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 52 -119.77 61.63 REMARK 500 THR A 163 -81.81 -91.33 REMARK 500 ALA A 176 -44.88 -141.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE D3A A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3Q30 RELATED DB: PDB REMARK 900 SAME PROTEIN REMARK 900 RELATED ID: 3ASX RELATED DB: PDB REMARK 900 SAME PROTEIN REMARK 900 RELATED ID: 3Q2Z RELATED DB: PDB REMARK 900 SAME PROTEIN DBREF 3V66 A 31 370 UNP P37268 FDFT_HUMAN 31 370 SEQRES 1 A 340 MET ASP GLN ASP SER LEU SER SER SER LEU LYS THR CYS SEQRES 2 A 340 TYR LYS TYR LEU ASN GLN THR SER ARG SER PHE ALA ALA SEQRES 3 A 340 VAL ILE GLN ALA LEU ASP GLY GLU MET ARG ASN ALA VAL SEQRES 4 A 340 CYS ILE PHE TYR LEU VAL LEU ARG ALA LEU ASP THR LEU SEQRES 5 A 340 GLU ASP ASP MET THR ILE SER VAL GLU LYS LYS VAL PRO SEQRES 6 A 340 LEU LEU HIS ASN PHE HIS SER PHE LEU TYR GLN PRO ASP SEQRES 7 A 340 TRP ARG PHE MET GLU SER LYS GLU LYS ASP ARG GLN VAL SEQRES 8 A 340 LEU GLU ASP PHE PRO THR ILE SER LEU GLU PHE ARG ASN SEQRES 9 A 340 LEU ALA GLU LYS TYR GLN THR VAL ILE ALA ASP ILE CYS SEQRES 10 A 340 ARG ARG MET GLY ILE GLY MET ALA GLU PHE LEU ASP LYS SEQRES 11 A 340 HIS VAL THR SER GLU GLN GLU TRP ASP LYS TYR CYS HIS SEQRES 12 A 340 TYR VAL ALA GLY LEU VAL GLY ILE GLY LEU SER ARG LEU SEQRES 13 A 340 PHE SER ALA SER GLU PHE GLU ASP PRO LEU VAL GLY GLU SEQRES 14 A 340 ASP THR GLU ARG ALA ASN SER MET GLY LEU PHE LEU GLN SEQRES 15 A 340 LYS THR ASN ILE ILE ARG ASP TYR LEU GLU ASP GLN GLN SEQRES 16 A 340 GLY GLY ARG GLU PHE TRP PRO GLN GLU VAL TRP SER ARG SEQRES 17 A 340 TYR VAL LYS LYS LEU GLY ASP PHE ALA LYS PRO GLU ASN SEQRES 18 A 340 ILE ASP LEU ALA VAL GLN CYS LEU ASN GLU LEU ILE THR SEQRES 19 A 340 ASN ALA LEU HIS HIS ILE PRO ASP VAL ILE THR TYR LEU SEQRES 20 A 340 SER ARG LEU ARG ASN GLN SER VAL PHE ASN PHE CYS ALA SEQRES 21 A 340 ILE PRO GLN VAL MET ALA ILE ALA THR LEU ALA ALA CYS SEQRES 22 A 340 TYR ASN ASN GLN GLN VAL PHE LYS GLY ALA VAL LYS ILE SEQRES 23 A 340 ARG LYS GLY GLN ALA VAL THR LEU MET MET ASP ALA THR SEQRES 24 A 340 ASN MET PRO ALA VAL LYS ALA ILE ILE TYR GLN TYR MET SEQRES 25 A 340 GLU GLU ILE TYR HIS ARG ILE PRO ASP SER ASP PRO SER SEQRES 26 A 340 SER SER LYS THR ARG GLN ILE ILE SER THR ILE ARG THR SEQRES 27 A 340 GLN ASN HET PO4 A 401 5 HET D3A A 402 38 HETNAM PO4 PHOSPHATE ION HETNAM D3A (1-{[(4R,6S)-8-CHLORO-6-(2,3-DIMETHOXYPHENYL)-4H,6H- HETNAM 2 D3A PYRROLO[1,2-A][4,1]BENZOXAZEPIN-4-YL]ACETYL}PIPERIDIN- HETNAM 3 D3A 4-YL)ACETIC ACID HETSYN D3A 2-(1-{2-[(4R,6S)-8-CHLORO-6-(2,3-DIMETHOXYPHENYL)-4H, HETSYN 2 D3A 6H-PYRROLO[1,2-A][4,1]BENZOXAZEPIN-4-YL]ACETYL}-4- HETSYN 3 D3A PIPERIDINYL)ACET IC ACID FORMUL 2 PO4 O4 P 3- FORMUL 3 D3A C29 H31 CL N2 O6 FORMUL 4 HOH *337(H2 O) HELIX 1 1 SER A 37 ARG A 52 1 16 HELIX 2 2 PHE A 54 ALA A 60 1 7 HELIX 3 3 GLU A 64 ASP A 85 1 22 HELIX 4 4 SER A 89 LEU A 104 1 16 HELIX 5 5 ARG A 119 ASP A 124 1 6 HELIX 6 6 ASP A 124 LEU A 135 1 12 HELIX 7 7 ALA A 136 LEU A 158 1 23 HELIX 8 8 SER A 164 ALA A 176 1 13 HELIX 9 9 ALA A 176 SER A 190 1 15 HELIX 10 10 ASP A 194 ASP A 200 1 7 HELIX 11 11 ASP A 200 ASP A 219 1 20 HELIX 12 12 ASP A 219 GLY A 226 1 8 HELIX 13 13 PRO A 232 SER A 237 1 6 HELIX 14 14 LYS A 242 GLU A 250 5 9 HELIX 15 15 ASN A 251 HIS A 268 1 18 HELIX 16 16 HIS A 269 ARG A 279 1 11 HELIX 17 17 ASN A 282 TYR A 304 1 23 HELIX 18 18 ASN A 306 LYS A 311 5 6 HELIX 19 19 ARG A 317 ALA A 328 1 12 HELIX 20 20 ASN A 330 ILE A 349 1 20 HELIX 21 21 SER A 355 ASN A 370 1 16 SITE 1 AC1 7 ARG A 148 ARG A 149 HIS A 173 TYR A 174 SITE 2 AC1 7 HOH A 545 HOH A 556 HOH A 589 SITE 1 AC2 15 SER A 53 PHE A 54 TYR A 73 VAL A 179 SITE 2 AC2 15 GLY A 180 LEU A 183 GLY A 208 LEU A 211 SITE 3 AC2 15 TYR A 276 PHE A 288 MET A 295 MET A 325 SITE 4 AC2 15 HOH A 735 HOH A 820 HOH A 833 CRYST1 87.438 60.144 85.797 90.00 117.14 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011437 0.000000 0.005863 0.00000 SCALE2 0.000000 0.016627 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013098 0.00000